Skip to main content
Transaction

Herter & Co. – Teneo Capital Advisory – Advised Luxempart on its Partnership with GNS Gesellschaft für Neurologie und seelische Gesundheit mbH (“VALEARA”)

By 22. December 2025No Comments

Herter & Co. – Teneo Capital Advisory – Advised Luxempart on its Partnership with GNS Gesellschaft für Neurologie und seelische Gesundheit mbH (“VALEARA”)

Herter & Co. – Teneo Capital Advisory – advised Luxempart on the financing of its partnership with VALEARA. The transaction is expected to close in the first quarter of 2026.

Herter & Co. – Teneo Capital Advisory – acted as Exclusive Debt Advisor to Luxempart, coordinating a fast-paced competitive process and structuring an attractive financing package to support the company’s future growth plans.

VALEARA stands for a new era in outpatient mental health care. The interdisciplinary team has set itself a clear mission: to reduce the stigmatization of mental illness and to close gaps in care wherever people need support – between hospital and home, during waiting periods for psychotherapy, and in accompanying individuals on their way back to a structured everyday life. As an employer, VALEARA views emotions as an essential part of being human. This shapes its culture and leadership philosophy. VALEARA stands for genuine collaboration, a high level of personal responsibility and a balance between empathy and performance – individually and as a community.

Luxempart is a Luxembourg-based listed investment company with a net worth of EUR 2.3bn backed by Luxembourgish entrepreneurial families. With permanent capital and a professional investment team, Luxempart provides flexible long-term financing solutions to entrepreneurs, families and management and actively supports its portfolio companies in their growth and international expansion. Luxempart’s Direct Investment strategy consists in investing equity tickets ranging from EUR 25m up to EUR 100m in the DACH region, France, BeLux and Northern Italy.